Company Filing History:
Years Active: 2007-2012
Title: The Innovative Contributions of Stacey A. Jones
Introduction
Stacey A. Jones is a prominent inventor based in Wake Forest, NC (US). She has made significant contributions to the field of biochemistry, particularly in the area of orphan nuclear receptors. With a total of 2 patents, her work has implications for drug interactions and toxicities.
Latest Patents
Stacey A. Jones holds two notable patents. The first patent, titled "Orphan Nuclear Receptor," relates to a novel human orphan nuclear receptor that binds to a cytochrome P-450 monooxygenase (CYP) promoter. This receptor is activated by compounds that induce CYP gene expression. The invention includes nucleic acid sequences encoding the receptor, methods of making the receptor, and methods of using the receptor and its encoding nucleic acid sequences. Additionally, the invention encompasses non-human animals transformed to express the human receptor, along with methods for using these animals to screen compounds for drug interactions and toxicities.
The second patent, "Pregnane X Receptor Method," shares similar themes, focusing on the same orphan nuclear receptor and its applications in drug interaction screening and toxicity assessments.
Career Highlights
Throughout her career, Stacey has worked with notable companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. Her experience in these organizations has contributed to her expertise in the field of biochemistry and patent development.
Collaborations
Stacey has collaborated with esteemed colleagues, including Steven Anthony Kliewer and Timothy Mark Willson. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Stacey A. Jones is a trailblazer in the field of orphan nuclear receptors, with her patents paving the way for advancements in drug interaction and toxicity screening. Her contributions continue to impact the scientific community and the development of new therapeutic approaches.